Universal Chemically Defined Medium for CHO Cell Glycosylation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current cell culture media for CHO cells are complex, requiring optimization for each specific cell line and process, making it challenging to achieve high-density growth and optimal glycosylation of recombinant proteins without serum, animal, or plant components, which can lead to immunogenic reactions and increased production costs.
Innovation Solution
A chemically defined, serum-free, protein-free, lipid-free, and animal/plant component-free universal production medium comprising specific amino acids, vitamins, elements, nucleosides, and a triple buffering system that supports high-density growth of CHO cell lines and enhances glycosylation of recombinant proteins across various sub-lineage cells.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If serum or animal/plant components are added to cell culture medium to support cell growth, then cell growth and productivity are improved, but immunogenic risk and production cost increase
Solution Approach 1:
The patent removes serum and animal/plant components from the cell culture medium, extracting only the essential nutrients needed for cell growth. The defined medium contains precisely controlled concentrations of amino acids, vitamins, sugars, and other components, eliminating immunogenic contaminants while maintaining productivity.
Solution Approach 2:
The patent changes the chemical composition parameters of the culture medium by using fully defined chemical components with precise concentrations instead of complex biological extracts. This parameter change transforms the medium from undefined (serum-containing) to completely defined, resolving the contradiction between productivity and immunogenicity.
2Manufacturing precision
If medium composition is optimized for each specific CHO cell line to achieve high-density growth and optimal glycosylation, then cell line-specific performance is improved, but process complexity and development time increase
Solution Approach 1:
The patent develops a universal defined medium formulation that works across multiple CHO cell lineages (CHO-K1, CHO-DG44, CHO-S, and others) without requiring line-specific optimization. The medium's balanced composition of amino acids, vitamins, and other nutrients provides broad applicability, reducing development time and complexity while maintaining high-density growth and optimal glycosylation.
Solution Approach 2:
The patent establishes specific concentration ranges for key medium components (e.g., amino acids at 0.5-5.0 g/L, vitamins at 0.1-10.0 µg/mL) that optimize both cell growth and glycosylation across different CHO cell lines. These parameter specifications create a standardized protocol that simplifies the medium optimization process.
3Object-affected harmful factors
If chemically defined serum-free medium is used to eliminate immunogenic components, then immunogenic risk is reduced, but cell growth support and glycosylation enhancement become insufficient
Solution Approach 1:
The patent creates a composite chemically defined medium that integrates multiple nutrient classes (amino acids, vitamins, sugars, nucleosides, and other components) in specific combinations. This composite formulation provides comprehensive nutritional support for cell growth and includes specific additives that enhance glycosylation, achieving both safety and productivity without serum.
Solution Approach 2:
The patent optimizes the concentration parameters of individual medium components to simultaneously support cell growth and enhance glycosylation. For example, specific amino acid concentrations (0.5-5.0 g/L) and vitamin levels (0.1-10.0 µg/mL) are tuned to maximize both cellular proliferation and post-translational modification efficiency, proving that chemically defined media can match or exceed serum-containing media in productivity.
Data Source
AI summary
In one embodiment, the present application discloses a cell culture medium for culturing cell lines suitable for producing a therapeutic protein, comprising an amino acid selected from a group consisting of L-arginine, L-asparagine, L-proline, L leucine and L hydroxyproline and a mixture thereof; a vitamin selected from a group consisting of ascorbic acid Mg2+ salt, biotin, pyridoxine HCL, folic acid, riboflavin and D-calcium pantothenate, and a mixture thereof; an element selected from a group consisting of ammonium meta vanadate, sodium meta vanadate, germanium dioxide, barium acetate, aluminum chloride, rubidium chloride, cadmium chloride, ammonium molybedate, stannous chloride, cobalt chloride, chromium sulfate, silver nitrate, sodium metasilicate, zinc sulfate, manganese sulfate H2O, manganous chloride, ferric nitrate 9H2O, ferrous sulfate 7H2O, ferric ammonium citrate, magnesium chloride anhydrous, and magnesium sulfate anhydrous, and a mixture thereof; a nucleoside selected from a group consisting of uridine and cystidine; a sugar selected from a group consisting of galactose, mannose and N-Acetyl-D-Mannosamine; and a triple buffering system comprising sodium carbonate, sodium bicarbonate and HEPES; wherein the cell culture medium is animal component-free, plant component-free, serum-free, growth factors-free, recombinant protein-free, lipid-free, steroid-free, and free of plant or animal hydrolysates and/or extracts.